#Obesity #Type2diabetes #EliLilly #Foundayo #orforglipron #regulatoryapproval #UK #MHRA #pharmanews #MarketAccess #oralGLP1agonist #weightmanagement #weightloss #weightmaintenance #GLP1receptoragonists #privateprescription #NHSReimbursement #NICE #cardiometabolicmedicine
zurl.co/o9OI7
zurl.co/o9OI7
UK is first European country to approve Lilly's Foundayo
Eli Lilly's oral GLP-1 agonist Foundayo has been approved for weight management and type 2 diabetes in the UK, its first European market.
zurl.co
August 11, 2026 at 2:24 PM
#Obesity #EliLilly #Foundayo #orforglipron #UK #MHRA #oralGLP1agonist #weightmanagement #weightloss #weightmaintenance #healthcarequality #patientaccess #GLP1receptoragonists #NHSReimbursement #NICE #NICEevaluation #NICEpreliminaryguidance #cardiometabolicmedicine
zurl.co/c9uL0
zurl.co/c9uL0
UK is first European country to approve Lilly's Foundayo
Eli Lilly's oral GLP-1 agonist Foundayo has been approved for weight management and type 2 diabetes in the UK, its first European market.
zurl.co
August 13, 2026 at 12:39 PM
#obesity #weightloss #weightlosstrial #GreaterManchester #weightlossjabs #weightlossmedication #realworldstudy #weightlossdrug #Mounjaro #GLP1drug #Tirzepatide #obesitytreatment #Zepbound #EliLilly #publichealth #cardiometabolicmedicine #weightrelatedhealthconditions
zurl.co/MmyhW
zurl.co/MmyhW
The £279m trial starting in Greater Manchester that could affect thousands
Up to 3,000 people will take part
www.manchestereveningnews.co.uk
December 24, 2025 at 10:51 AM
We're delighted to share @DrRajThakkar, PCCS President, will feature as joint chair of the Nephrology session on 20 March at the 2nd Postgraduate Course in Cardiometabolic Medicine, 19-21 March @RoySocMed Register: www.zhh.ch/en/agenda/po... #CardiometabolicMedicine @zhh_ch
February 3, 2025 at 12:19 PM
We're delighted to share @DrRajThakkar, PCCS President, will feature as joint chair of the Nephrology session on 20 March at the 2nd Postgraduate Course in Cardiometabolic Medicine, 19-21 March @RoySocMed Register: www.zhh.ch/en/agenda/po... #CardiometabolicMedicine @zhh_ch